NCT05053555View on ClinicalTrials.gov

High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 24, 2022

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Liver Malignant TumorsCholangiocarcinoma MetastaticPancreatic CancerMelanoma
Interventions
DEVICE

high dose rate brachytherapy

diagnostic workup, staging, and treatment per the institution standard of care

DEVICE

high dose rate brachytherapy

reviewing historical patients who meet the above criteria for group A but did not receive HDRBT between 01/01/2000 and 1/01/2021

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER